IMMR
Immersion Corporation
IMMR trails on the overall score without a compensating advantage in the available component scores.
MSFT
Microsoft Corporation
MSFT has the edge over IMMR overall, supported by stronger valuation and stronger modeled upside.
IMMR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
IMMR's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
IMMR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.8x | $0.95 | -86% |
| Fair | 7.4x | $2.51 | -64% |
| Expensive | 20x | $6.92 | -0.7% |
| Current | 21x | $6.97 | — |
Historical ranges are pointers, not guarantees.
IMMR's PE is in its expensive range at 21x.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over IMMR in the historical PE scenario, which offers more potential upside but is not a forecast.
IMMR Forward outlook
There aren't enough analyst estimates for IMMR to show an outlook.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
IMMR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.34 | -51% |
| Q1 2024 | $1.38 | +35% |
| Q4 2023 | $1.04 | +13% |
| Q3 2023 | $1.13 | +214% |
| Q2 2023 | $1.28 | +412% |
| Q1 2023 | $1.02 | +117% |
| Q4 2022 | $0.92 | +136% |
| Q3 2022 | $0.36 | -43% |
IMMR's earnings per share have fallen from their peak: $0.34 over the past year, against $1.38 in early 2024.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT's earnings per share have climbed steadily: $19.15 over the past year, up 36% from the year before, and higher year over year for 14 quarters in a row.
IMMR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $294.4M | +0.8% |
| Q2 2026 | $270M | -5.2% |
| Q1 2026 | $518.5M | +9.2% |
| Q4 2025 | $650.2M | +5.5% |
| Q3 2025 | $292M | +194% |
| Q2 2025 | $284.9M | +522% |
| Q1 2025 | $474.8M | +4474% |
| Q4 2024 | $616.2M | +6399% |
IMMR's revenue has held roughly level: $294M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.8% | +2.2 points |
| Q2 2026 | 2.7% | +3.1 points |
| Q1 2026 | 1% | -4.6 points |
| Q4 2025 | 6.2% | -4.3 points |
| Q3 2025 | -9% | -35 points |
| Q2 2025 | -0.4% | -35 points |
| Q1 2025 | 5.5% | -32 points |
| Q4 2024 | 10% | -38 points |
IMMR's operating margin was −6.8% last quarter, up 2.2 points from the same quarter a year ago.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT's revenue has grown year over year every quarter since late 2020: $92.3B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over IMMR on profitability, with a higher operating margin.
IMMR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.1M | +$18.3M |
| Q2 2026 | $79.4M | +69% |
| Q1 2026 | -$37.5M | +$8.8M |
| Q2 2025 | $47M | +49% |
| Q1 2025 | -$46.2M | -691% |
| Q2 2024 | $31.6M | +797% |
| Q1 2024 | $29.9M | +749% |
| Q4 2023 | $7.8M | -3% |
IMMR has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
IMMR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +176K shares |
| 1 year | +2.1% | +688K shares |
| 3 years | +1.7% | +553K shares |
| 5 years | +6.6% | +2.1M shares |
| Available history | +4.4% | +1.4M shares |
IMMR has 33M diluted shares, up 2.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $2.1M |
| Q3 2023 | $3.3M |
| Q2 2023 | $2.9M |
| Q1 2023 | — |
| Q4 2022 | $2M |
| Q3 2022 | $5.2M |
| Q2 2022 | $1.6M |
| Q1 2022 | $4.4M |
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has the edge over IMMR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
IMMR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q1 2024 | -2.9x | Net Cash |
| Q4 2023 | -3.1x | Net Cash |
| Q3 2023 | -1.5x | Net Cash |
| Q2 2022 | -3.2x | Net Cash |
IMMR has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
IMMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 26.0 | Neutral |
IMMR's weekly RSI is 49 (neutral) and its Stochastic is 26 (neutral).
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
IMMR PE vs Technology Sector
| Metric | IMMR | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 26% below |
| PE % | 84 | 35 | 49 pts above |
IMMR has the edge over MSFT on valuation relative to its sector.
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
IMMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.14 | 2.4% below |
| 20 week MA | $7.20 | 3.2% below |
| 50 week MA | $6.70 | 4% above |
| 100 week MA | $7.11 | 2% below |
| 200 week MA | $7.51 | 7.2% below |
IMMR's trend is mixed: it's above one of its five weekly moving averages, and 7.2% below its 200-week average.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over IMMR on trend strength, trading above more of its moving averages.
IMMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.58 | $8.93 | +18% |
| 2021 | $8.93 | $6.10 | -32% |
| 2022 | $6.10 | $7.33 | +20% |
| 2023 | $7.33 | $7.06 | -3.7% |
| 2024 | $7.06 | $9.00 | +27% |
| 2025 | $9.00 | $6.85 | -24% |
| 2026 YTD | $6.85 | $6.97 | +1.8% |
IMMR has finished lower in three of the last six years. It's up 1.8% so far in 2026.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over IMMR on returns for 2026, with the stronger performance.